| Literature DB >> 23504500 |
Abstract
Providing undergraduate neuroscience students an appropriate laboratory experience that demonstrates principles of neurotransmission and drug action is a difficult task. In the following activity, fast-scan cyclic voltammetry was utilized to measure dopamine levels using carbon-fiber microelectrodes in rats in vivo. Recordings were made before and after administration of several drugs to assess their ability to alter extracellular dopamine. The following drugs were chosen due to their well established actions: haloperidol, methylphenidate, and alpha-methyl-para-tyrosine. Each demonstrated markedly altered extracellular dopamine dynamics and some basic kinetic analysis enabled students to attribute the alterations to differing modes of action. Dopamine tissue content was also assessed to compare the differences between acute drug action and overall neurotransmitter content. Any neuroscience laboratory course that desired to demonstrate principles involved in neurotransmission would be well served by the activities involved. This laboratory experience provided: 1) basic principles in experimental design, 2) small animal surgical experiences, 3) exposure to common instrumentation used in collecting neurochemical data, 4) data analysis procedures, and 5) experience in presenting their findings.Entities:
Keywords: alpha-methyl-para-tyrosine; carbon-fiber microelectrode; dopamine; dopamine transporter; fast-scan cyclic voltammetry; haloperidol; methylphenidate
Year: 2012 PMID: 23504500 PMCID: PMC3598088
Source DB: PubMed Journal: J Undergrad Neurosci Educ ISSN: 1544-2896
Figure 1Representative Voltammetric Recordings. Each circle in panels A-D represents the concentration of dopamine at 100 ms intervals. Filled circles (•) represent recordings pre-injection and open circles (○) represent post-injection values. Panel A: Haloperidol; Panel B: Methylphenidate; Panel C: Alpha-methyl-para-tyrosine; Panel D: Saline.
Kinetic Analysis of Voltammetric Traces
| Parameter | Haloperidol | Methylphenidate | AMPT | Saline | ||||
|---|---|---|---|---|---|---|---|---|
| Pre-Inj. | Post-Inj. | Pre-Inj. | Post-Inj. | Pre-Inj. | Post-Inj. | Pre-Inj. | Post-Inj. | |
| DAp (μM) | 0.022±0.001 | 0.016±0.002 | 0.014±0.002 | 0.025±0.004 | 0.032±0.001 | 0.033±0.002 | ||
| Vmax (μM/s) | 4.6±0.3 | 5.7±0.9 | 6.2±1.2 | 5.1±0.5 | 6.4±0.2 | 6.1±0.4 | ||
Km was fixed at 0.2 μM for all curve-fitting.
All groups possessed an n = 3.
An * represents a significant difference with p < 0.05.
Figure 2Dopamine Tissue Content. All groups had an n = 3 and represent the dopamine content from the approximate location of the recording site. Dopamine content values showed a significant effect of treatment (F(3,11)=7.6; p <0.01).